Security readout for executives and security teams
Plain-English summary
CVE-2021-37499 affects the Reprise License Manager web interface through 14.2BL4. A flaw in a password field can let an attacker inject HTTP headers into a response. The main business risk is response manipulation, not data theft or service outage based on the supplied CVSS data.
Executive priority
Treat this as a moderate-priority exposure reduction task. It is not supported as actively exploited, but exposed license-management interfaces can create avoidable integrity risk and should be inventoried, access-restricted, and updated according to vendor guidance.
Technical view
The View License Result function in the RLM web interface has a CRLF injection issue in the password parameter. Sources describe arbitrary HTTP header injection by remote attackers. CVSS 3.1 is 6.5 with network access, low complexity, no privileges, required user interaction, and high integrity impact.
Likely exposure
Exposure is most likely where Reprise License Manager web interfaces through 14.2BL4 are reachable by users or the internet. The source bundle provides no CPEs or broader affected product list, so asset confirmation is required before scoping impact.
Exploitation context
The CVE is not listed as KEV, and the provided sources do not state active exploitation. The advisory evidence supports a remotely reachable header-injection flaw, but not exploitation in the wild, a public weaponized exploit, or confirmed compromise patterns.
Researcher notes
Evidence is limited to the CVE record and a public advisory reference. The affected data in the bundle lacks CPEs and normalized vendor/product fields. Do not assume other Reprise components or downstream products are affected without confirmation from their maintainers.
Mitigation direction
- Inventory RLM web interfaces and identify versions at or below 14.2BL4.
- Check Reprise or product-vendor guidance for fixed versions or official mitigations.
- Restrict RLM web interface access to trusted admin networks where possible.
- Remove public internet exposure for license management interfaces if not required.
- Monitor proxy and application logs for suspicious response-header anomalies.
Validation and detection
- Confirm whether any RLM web interface is deployed in the environment.
- Verify deployed RLM versions against the affected through-14.2BL4 statement.
- Review whether the View License Result function is reachable by untrusted users.
- Check whether network controls limit access to the RLM web interface.
- Look for historical reports of abnormal headers or response-splitting behavior.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CWE-74: Exact CWE lookup
Use the exact CWE identifier as the starting point before reviewing related ATT&CK behavior. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.
Open ATT&CK lookupCredential and access behavior lookup
The CVE wording references authentication or credential exposure, so valid-account and credential-access review may help. This is a Glexia inferred lookup path, not an official MITRE, ATT&CK, or CVE Program mapping.
Open ATT&CK lookupCVE-2021-37499 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Medium
- CVSS
- 6.5 (3.1)
- Known Exploited
- No
- Published
Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
SSVC decision data
CVSS vector scores
1 official scoreWe collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N2.83.6CISA-ADPVulnerability scoring details
Base CVSS 3.1 score
6.5MediumVector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N
Vulnerability timeline
Timeline events are normalized from CVE metadata, CNA source timelines, ADP timelines, and KEV metadata when present.
- CVE reservedCVE Program
The CVE ID was reserved by the assigning CNA.
- CVE publishedCVE Program
The CVE record was published.
- CVE updatedCVE Program
The CVE record metadata indicates this as the latest update time.
ADP provider summaries
Source materials
- CVE List V5 sourceCVE List V5
- https://github.com/blakduk/Advisories/blob/main/Reprise%20License%20Manager/README.mdCVE reference, mitre
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.
Improper Neutralization of Special Elements in Output Used by a Downstream Component ('Injection')
Improper Neutralization of Special Elements in Output Used by a Downstream Component ('Injection') represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.